| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00535-013-0812-3 |
| P698 | PubMed publication ID | 23653056 |
| P50 | author | Ken Haruma | Q94925672 |
| Yoshikazu Kinoshita | Q108291777 | ||
| P2093 | author name string | Hiroto Miwa | |
| Katsuyuki Sanada | |||
| Koji Miyata | |||
| P2860 | cites work | Pharmacological interventions for non-ulcer dyspepsia | Q24244245 |
| Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials | Q30433544 | ||
| A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care | Q34161159 | ||
| A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study | Q34558898 | ||
| The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus | Q34570296 | ||
| Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). | Q34755597 | ||
| Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan | Q81561026 | ||
| Importance of vertebral fracture and body mass index in the pathogenesis of gastroesophageal reflux disease | Q81975325 | ||
| Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects | Q82513699 | ||
| Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidification | Q83200851 | ||
| Proton pump inhibitor step-down therapy for GERD: a multi-center study in Japan | Q34756783 | ||
| Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial | Q35039951 | ||
| The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies | Q35790399 | ||
| Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese | Q35841100 | ||
| Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia | Q35872064 | ||
| Asian consensus report on functional dyspepsia | Q35885912 | ||
| Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next? | Q36191254 | ||
| Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications | Q36215395 | ||
| Impaired gastric accommodation and its role in dyspepsia | Q36541253 | ||
| Epidemiology and clinical characteristics of GERD in the Japanese population | Q37443906 | ||
| Duodenal hypersensitivity to acid in patients with functional dyspepsia-pathogenesis and evaluation | Q37728805 | ||
| Systematic review of the epidemiology of gastroesophageal reflux disease in Japan | Q37892964 | ||
| Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Rese | Q39260588 | ||
| Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL. | Q39299676 | ||
| Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study | Q39367299 | ||
| Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. | Q39399125 | ||
| Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group | Q39492284 | ||
| Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study | Q39674010 | ||
| Characteristics of Japanese patients with chronic gastritis and comparison with functional dyspepsia defined by ROME III criteria: based on the large-scale survey, FUTURE study | Q39697092 | ||
| Atypical symptoms in patients with gastroesophageal reflux disease | Q41830702 | ||
| Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis | Q41881124 | ||
| Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms | Q42132392 | ||
| Clinical symptoms in endoscopic reflux esophagitis: evaluation in 8031 adult subjects | Q43916290 | ||
| The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study | Q44556223 | ||
| Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy | Q46184104 | ||
| Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease | Q48483165 | ||
| Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. | Q51035370 | ||
| Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. | Q51536392 | ||
| Impaired accommodation of proximal stomach to a meal in functional dyspepsia. | Q51582132 | ||
| Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. | Q51674445 | ||
| Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. | Q51848674 | ||
| Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a population-based study | Q57211813 | ||
| Non-erosive reflux disease (NERD)--acid reflux and symptom patterns | Q73092305 | ||
| Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings | Q73117411 | ||
| Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis | Q73292394 | ||
| Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan | Q73442611 | ||
| Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis | Q77349047 | ||
| Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy | Q78144360 | ||
| Proton pump inhibitors improve acid-related dyspepsia in gastroesophageal reflux disease patients | Q80036132 | ||
| Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire | Q80170431 | ||
| Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects | Q80530469 | ||
| Validity of endoscopic classification of nonerosive reflux disease | Q80727273 | ||
| Development and evaluation of FSSG: frequency scale for the symptoms of GERD | Q81061006 | ||
| P433 | issue | 4 | |
| P921 | main subject | gastroesophageal reflux disease | Q223591 |
| P304 | page(s) | 628-637 | |
| P577 | publication date | 2013-05-08 | |
| P1433 | published in | Journal of Gastroenterology | Q15764399 |
| P1476 | title | Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia | |
| P478 | volume | 49 |
| Q91763142 | Barretts's carcinogenesis |
| Q58541866 | Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders |
| Q41602458 | No increase in gastric acid secretion in healthy Japanese over the past two decades |
| Q88173998 | Reply to the letter by E. Savarino et al. regarding "The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders" |
| Q88171099 | The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders |
Search more.